Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats
Human Gene Therapy Clinical Development · 2013
DOI: 10.1089/hum.2013.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2013. Verfasst von Stephen Kaminsky und 11 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kaminsky, S., Quach, L., Chen, S., Graaf, B. V. D., Monette, S., Rosenberg, J., De, B., Sondhi, D., Hackett, N., Mezey, J., Ronsengart, T., & Crystal, R. (2013). Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2013.054
Vancouver
Kaminsky S, Quach L, Chen S, Graaf BVD, Monette S, Rosenberg J, et al. Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats. Human Gene Therapy Clinical Development. 2013. doi:10.1089/hum.2013.054
BibTeX
@article{Kaminsky2013,
author = {Kaminsky, Stephen and Quach, Lucy and Chen, Stacy and Graaf, Benjamin Van de and Monette, Sebastien and Rosenberg, Jonathan and De, Bishnu and Sondhi, Dolan and Hackett, Neil and Mezey, Jason and Ronsengart, Todd and Crystal, Ronald},
title = {Safety of Direct Cardiac Administration of AdVEGF-All6A+, a Replication Deficient Adenovirus Vector cDNA/Genomic Hybrid Expressing All Three Major Isoforms of Human Vascular Endothelial Growth Factor, to the Ischemic Myocardium of Rats},
journal = {Human Gene Therapy Clinical Development},
year = {2013},
doi = {10.1089/hum.2013.054}
}
EUVIMED